A VISIONaerie™ approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye
NEWSAerie Pharmaceuticals Establishes GMP PRINT® Production Facility in... Aerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory... Aerie Pharmaceuticals Reports Topline Result from Rhopressa®...
Dec 14, 4:00 PM ET
52 - WEEK LOW/HIGH